Melanoma Research Foundation Breakthrough Consortium
EIN: 800671049 · Washington, DC · NTEE: H30
| Metric | Value |
|---|---|
| Total Revenue | $391K |
| Total Expenses | $380K |
| Net Assets | $475K |
Is Melanoma Research Foundation Breakthrough Consortium Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
About Melanoma Research Foundation Breakthrough Consortium
Melanoma Research Foundation Breakthrough Consortium (EIN: 800671049) is a nonprofit organization based in Washington, DC, classified under NTEE code H30. The organization reported total revenue of $391K and total assets of $558K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Melanoma Research Foundation Breakthrough Consortium's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Melanoma Research Foundation Breakthrough Consortium is a small nonprofit that has been operating for 13 years, with 7 years of IRS 990 filings on record (2014–2020). Revenue has grown at a compound annual rate of -12.2%.
Key Financial Metrics (2020)
From the most recent IRS 990 filing on record:
| Total Revenue | $391K |
| Total Expenses | $380K |
| Surplus / Deficit | +$11K |
| Total Assets | $558K |
| Total Liabilities | $84K |
| Net Assets | $475K |
| Operating Margin | 2.8% |
| Debt-to-Asset Ratio | 15.0% |
| Months of Reserves | 17.7 months |
Financial Health Grade: A
In 2020, Melanoma Research Foundation Breakthrough Consortium reported a surplus of $11K with revenue exceeding expenses, holds 17.7 months of operating reserves (strong position), has a debt-to-asset ratio of 15.0% (very low leverage).
Financial Trends
Over 7 years of filings (2014–2020), Melanoma Research Foundation Breakthrough Consortium's revenue has declined at a compound annual growth rate (CAGR) of -12.2%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2020 | +4.1% | +316.8% | -7.5% |
| 2019 | -31.0% | -84.8% | +3.1% |
| 2018 | +142.9% | +147.2% | +91.9% |
| 2017 | -68.4% | -55.3% | -69.1% |
| 2016 | +423.3% | +230.7% | -21.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 2000 |
| IRS Ruling Date | 2013 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Melanoma Research Foundation Breakthrough Consortium has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Melanoma Research Foundation Breakthrough Consortium with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2020)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $11K, with revenue exceeding expenses.
- Debt-to-asset ratio: 15.0%.
Frequently Asked Questions about Melanoma Research Foundation Breakthrough Consortium
Is Melanoma Research Foundation Breakthrough Consortium a legitimate charity?
Melanoma Research Foundation Breakthrough Consortium (EIN: 800671049) is a registered tax-exempt nonprofit based in Washington DC. It has 7 years of IRS 990 filings on record. Total revenue: $391K. No red flags identified. Financial health grade: A.
How does Melanoma Research Foundation Breakthrough Consortium spend its money?
Melanoma Research Foundation Breakthrough Consortium reported $391K in total revenue in IRS 990 filings. 7 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Melanoma Research Foundation Breakthrough Consortium tax-deductible?
Melanoma Research Foundation Breakthrough Consortium is registered as a tax-exempt nonprofit (EIN: 800671049). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Melanoma Research Foundation Breakthrough Consortium located?
Melanoma Research Foundation Breakthrough Consortium is headquartered in Washington, Washington DC and files with the IRS under EIN 800671049. It is classified under NTEE code H30.
How many years of IRS 990 filings does Melanoma Research Foundation Breakthrough Consortium have?
Melanoma Research Foundation Breakthrough Consortium has 7 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $391K in total revenue.
Filing History
IRS 990 filing history for Melanoma Research Foundation Breakthrough Consortium showing financial trends over 7 years of public records:
Over 7 years of IRS 990 filings (2014–2020), Melanoma Research Foundation Breakthrough Consortium's revenue has declined by 54.3%, moving from $854K to $391K. Total assets decreased by 52.9% over the same period, from $1.2M to $558K. Total functional expenses fell by 60.3%, from $957K to $380K. In its most recent filing year (2020), Melanoma Research Foundation Breakthrough Consortium reported a surplus of $11K, with revenue exceeding expenses. The organization holds $84K in liabilities against $558K in assets (debt-to-asset ratio: 15.0%), resulting in net assets of $475K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2020 | $391K | $380K | $558K | $84K | — | View 990 |
| 2019 | $375K | $91K | $604K | $140K | — | View 990 |
| 2018 | $544K | $600K | $586K | $406K | — | View 990 |
| 2017 | $224K | $243K | $305K | $69K | — | — |
| 2016 | $709K | $543K | $987K | $732K | — | View 990 |
| 2015 | $135K | $164K | $1.3M | $1.2M | — | View 990 |
| 2014 | $854K | $957K | $1.2M | $1.1M | — | View 990 |
Year-by-Year Financial Summary
- 2020: Revenue of $391K, expenses of $380K, and assets of $558K (revenue +4.1% year-over-year).
- 2019: Revenue of $375K, expenses of $91K, and assets of $604K (revenue -31.0% year-over-year).
- 2018: Revenue of $544K, expenses of $600K, and assets of $586K (revenue +142.9% year-over-year).
- 2017: Revenue of $224K, expenses of $243K, and assets of $305K (revenue -68.4% year-over-year).
- 2016: Revenue of $709K, expenses of $543K, and assets of $987K (revenue +423.3% year-over-year).
- 2015: Revenue of $135K, expenses of $164K, and assets of $1.3M (revenue -84.1% year-over-year).
- 2014: Revenue of $854K, expenses of $957K, and assets of $1.2M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Melanoma Research Foundation Breakthrough Consortium:
Data Sources and Methodology
This transparency report for Melanoma Research Foundation Breakthrough Consortium is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.